ArticleNPJ digital medicine2026
KT-LLM: an evidence-grounded and sequence text framework for auditable kidney transplant modeling.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
We address a critical clinical gap in real-world kidney transplantation (KT), the long-standing disconnect between structured longitudinal follow-up and text-defined clinical rules, which often leads to inconsistent reporting, poor policy compliance, and non-reproducible outcomes across centers. To resolve this, we introduce KT-LLM, a verifiable orchestration layer that bridges sequence modeling with policy and terminology-aware reasoning, tailoring explicitly to KT clinical workflows. KT-LLM ensures clinical decision-making is grounded in authority by constraining knowledge access to Banff kidney allograft pathology references, OPTN, and SRTR policy documents via retrieval-augmented generation. This design anchors answers and computable checklists to versioned sources, enabling full auditability and reducing subjective interpretation errors. The system coordinates three clinically focused, auditable agents: (i) Agent-A (SRTR-MambaSurv): Optimizes discrete-time survival and competing risk prediction from TRF-aligned trajectories via a linear-time inference backbone to personalize follow-up scheduling; (ii) Agent-B (OPTN-BlackClust): identifies clinically distinct population subtypes using stable deep embedded clustering, supporting individualized treatment stratification; (iii) Agent-C (Policy-Ops): encodes OPTN and UNOS submission timelines, SRTR reporting cadence, and Banff terminology into executable rules, returning pass, warn and fail outcomes with versioned evidence to ensure policy compliance. On de-identified OPTN and UNOS cohorts, KT-LLM outperformed strong baselines in evidence attribution and predictive calibration. Critically, it retained the ability to surface clinically distinct subgroups among Black recipients, which aligns with prior reports of outcome heterogeneity, while avoiding overgeneralization of claims beyond the analyzed window. This supports equitable subgroup analysis while avoiding clinical overreach. By anchoring reasoning and outputs to versioned policies and terminology, KT-LLM transforms the model to govern KT workflows into an auditable, clock-synchronized process. This offers a practical solution to enhance reproducibility, monitor fairness across centers and eras, and standardize clinical practice, addressing unmet needs for scalable, reliable KT care in real-world settings.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.